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 ABSTRACT 
TITLE OF THE STUDY 
A study on micro albuminuria in acute ischemic stroke patients. 
BACKGROUND AND OBJECTIVES 
Stroke is a medical emergency and can cause permanent neurological damage, 
complication and death if not promptly diagnosed and treated. 
Micro albuminuria denote an abnormal increase in albumin excretion in urine. Albumin 
excretion range between 20-200 mcg/min or 30-299 mg/day. Role of micro albumin 
becomes apparent in acute diseases such as myocardial infarction and stroke. 
Present study evaluate the incidence of micro albuminuria in ischemic stroke and its co 
relation to other risk factors. 
METHODS 
This study was started after approval of institutional ethical committee.  This is a 
nonrandomized cross sectional study was done in medical wards and IMCU of the SREE 
MOOKAMBIKA INSTITUTE OF MEDICAL SCIENCES, Kulasekharam.  The study 
period was 18 months.  During this period 50 patients were included.  After meeting the 
eligibility criteria, a complete physical and systemic examination of the patients were 
done.  Then investigations mentioned in the protocol was sent and results were analysed. 
 
 
 STATISTICAL ANALYSIS 
The data was analysed by SPSS 16.0 with independent t-test. 
RESULTS 
In our study titled ‘A study on micro albuminuria in acute ischemic stroke patients’  a 
total number of 50 patients were studied.  In this 25 were males and 25 where females.  
The average age group of the patients were 51 to 70 years.  We found that the prevalence 
of micro albuminuria in patient with acute ischemic stroke was 74%. There was a strong 
possible relation of micro albuminuria as a risk factor for stroke. 
MCA was the most common territory, measures 64%.  Facial nerve was the most 
common cranial nerve involved with 64% of total case. 62% had ECG showing LVH 
pattern and there was strong correlation with micro albuminuria. 
Positive correlation between lipid profile and micro albuminuria in stroke patient. 
Significant correlation between blood sugar and blood pressure with microalbuminuria in 
acute ischemic stroke patients. 
 
CONCLUSION 
In our study we have found out that there is a statistically significant association between 
microalbuminuria and incidence of acute ischemic stroke.  
 
 
 
 SUMMARY 
We conducted a study titled “A STUDY ON MICROALBUMINURIA IN 
ACUTE ISCHEMIC STROKE PATIENTS” which was done as a non-randomized cross 
sectional study in the medicine wards and IMCU of Sree Mookambika Institute of 
Medical Sciences, Kulasekharam for 18 months study period on 50 ischemic stroke 
patients admitted and met pre-defined criteria gave informed consent after obtaining 
ethical clearance from the institutions ethical clearance committee. 
In our study of 50 patients with ischaemic stroke, 74% had significant 
microalbuminuria.  MCA was the most common territory involved with 64% cases 
followed by PCA in 10 % and ACA IN 8 %.  But no significant correlation of 
microalbuminuria with particular vascular territory has found out.  In our study 62 % 
cases had ECG showing LVH pattern. crainal nerve involvement most commonly facial 
nerve was seen in 74% of all cases. There was a positive co-relation between lipid profile 
and LVH with microalbuminuria .  There is statistically significant co-relation between 
elevated blood sugar and elevated blood pressure in patients admitted with ischemic 
stroke less than 24hours. There was strong positive relationship of microalbuminuria in 
acute ischemic stroke patients and microalbuminuria is  an important independent  risk 
factor for stroke. 
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Following are the main risk factors of stroke in India. Though there are no 
sufficient amount of data available about the co-existent risk factors in India and 
other south Asian countries, the following 3 transitions(demographic, 
socioeconomic, life style) which increase both the modifiable and non-modifiable 
risk factors of stroke.6-7  For example lifestyle modifications like reduced physical 
activity, increased food intake and demographic changes like  increase life 
expectancy are the reasons of increased prevalence of risk factors of stroke.  Age, 
sex, low birth weight, ethnicity and genetic factors are the important non 
modifiable risk factors.  
Patients with hypertension and diabetes are already at a risk for cerebro-
vascular events, in addition to this microalbuminuria is studied to be an 
independent risk factor for stroke.  
 The correlation of microalbuminuria with other risk factors of stroke such 
as diabetes and hypertension has been studied in the past, and most studies show a 
very strong association in predicting stroke and also as a predictor of mortality post 
stroke.        
As per the study in Gujarat, the commonest causes of stroke in elderly 
people are hypertension(40%), alcoholism(35%), smoking(23%) and 
hyperlipidemia(17%).  In young people, the common causes are smoking, 
alcoholism, increased BMI, diabetes and hypertension.  The risk factor for 
atherosclerosis in large vessel and occlusion of small vessel are hypertension and 
diabetes. 
4 
 
             Microalbuminuria denotes an abnormal increase in albumin excretion in 
urine below the lower limits of sensitivity for routine diagnostic methods.8 
The current National Kidney Foundation’s definition of microalbuminuria is 
excretion rate of  Urinary Albumin is between 20-200 microgram/min or 30-
299mg/day9, which was used as a marker for incipient diabetic nephropathy. 
In past decade the role of microalbuminuria has become apparent in 
Myocardial Infarction and stroke.10 
 Microalbuminuria indicates irregularity of the microvasculature of the 
kidney.  It also indicates the global endothelial dysfunction of kidney that is 
associated with increased risk of cerebrovascular events like stroke11-12.  The 
current proposed patho physiological mechanism is through local vascular smooth 
muscle and endothelial cells injury due to vascular shear stress,  changes in Nitric 
Oxide  and increase in cytokines and increased vascular permeability. Other studies 
have also shown that the presence of microalbuminuria post stroke or episodes of 
transient ischemic attacks is also a very strong indicator of recurrence of stroke 
with or without other risk factors for stroke. It is also said that microalbuminuria is 
associated with vascular disorder of heart and kidney similar to those of 
cerebrovascular disease.  
          Estimating microalbuminuria is a simple noninvasive dip stick 
procedure, which opens to the window for prediction of several vascular events and 
its association with various other major risk factors.  
 
5 
 
AIMS AND OBJECTIVES 
 
      The aims and objectives of this study were :- 
• To know the incidence of microalbuminuria in acute ischemic stroke  patients         
( i.e less than 24 hours). 
• Role of microalbuminuria as a  risk factor in stroke. 
• Prevalence of microalbuminuria in different subtypes of ischemic strokes  (MCA/ 
ACA/ PCA) 
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HYPOTHESIS AND SCIENTIFIC JUSTIFICATION  
Scientific Justification of the study:  
          One of the leading causes of diability and death is stroke.  It is mainly due to 
the increased prevalence of modifiable risk factors, demographic changes, doubling 
the burden of non-communicable diseases.  The impact of stroke is more in poor 
people due to change in prevalence of risk factors and inability to afford the high 
cost stroke treatment.            
          Most of the stroke survivors live with disability so that family members have 
to spend lots of money for rehabilitation which leads to poverty in the family. 
           The role of risk factors such as hypertension, smoking, diabetes, 
dyslipidemia in the cause of stroke has been in substantial progress.  However, 
uncertainty remains regarding the significance of more novel risk factors in 
contributing to the burden of stroke. In particular, several prospective studies have 
suggested that the presence of protein in urine is associated directly with 
cardiovascular events, including stroke14-20. Better understanding of the precise 
nature of the relationship between proteinuria and stroke is important from both a 
clinical and public health perspective. 
             Even though microalbuminuria is associated with diabetes, hypertension, 
ageing, history of myocardial infarction, left ventricular hypertrophy which are the 
risk factors for stroke, there is only little information about  microalbuminuria as a 
predictor or independent risk factor of stroke21. 
7 
 
              Over the last 4 decades, several   prospective clinical studies have 
identified a series of independent risk factors for symptomatic vascular events 
including stroke and also showed a better understanding of the multifactorial 
pathogenesis of atherosclerosis. The underlying entity behind most vascular events 
and the fact that many of these event occur in persons who do not harbor 
convusional vascular risk factors has promoted to search  novel risk factors for 
prediction of stroke.  
        The clinical value of many of these emergency risk factors remain uncertain. 
One such emerging vascular risk factor is microalbuminuria. Microalbuminuria is 
an independent risk factor for stroke and also interacts with several vascular risk 
factors.   
         Though there is convincing evidence of an independent positive relationship 
between overt proteinuria and stroke risk, but there is no investigations done to 
know the relationship between microalbuminuria and stroke incidence. In this 
study, our aim is to know the strength and consistency of association between 
microalbuminuria and the incidence of ischemic stroke. 
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REVIEW OF LITERATURE 
 
Stroke definition 
          As per the definition by WHO   stroke as a "neurological deficit of 
cerebrovascular cause that persists beyond 24hours 1 
Stroke Types2 
Stroke is classified 
Based on timing  
• Primary  
• Secondary/ recurrent  
Based on etiology  
• Ischemic stroke - about 83% of all stroke cases are ischemic stroke.   It is due to 
obstruction of  blood vessels supplying brain. 
• Hemorrhagic stroke occurs when there is rupture of a vessel or intracranial bleed. 
Based on how far it develops 
• Acute  
• Chronic  
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Modifiable Lifestyle Risk Factors  
Cigarette Smoking4 
Promotes stroke by the following factors. 
• Distensibility/compliance of blood vessel is reduced,  
• Fibrinogen levels increased,  
• Platelet aggregation increased,  
• HDL cholesterol levels decreased, and  
• Increased hematocrit  
• 18% of stroke patients give a history of active cigarette smoking.   Not only that, 
even passive cigarette smoking increase the risk of stroke by causing 
atherosclerosis progression. 
 
Alcohol Consumption 5 
Heavy alcohol consumption favors stroke by  
• Elevating blood pressure, increasing the coagulability 
• Enhancing the occurrence of cardiac arrhythmias, and  
• Decreasing the cerebral blood flow  
Sedentary life style Increased physical activity reduce the pro-athrogenic factors. 
As per the meta-analysis study done to know the relationship of physical activity 
with stroke risk, more active subjects had lower risk of stroke or mortality when 
compared to less active subjects. 
11 
 
Non-Modfiable Risk Factors 
Age as a predictor for stroke  
            An important non modifiable risk factor of stroke is age.  The risk of stroke 
incidence doubles per decade after  55 years of age6. 
           Stroke are rare in children most often due to hemorrhage. 
            In India stroke occurs at a younger age than other countries, which is 15 
years younger than other well developed countries. 
Gender as a predictor for stroke 7 
             Males are more prone for development of stroke than females , but the 
severity of stroke is more in females. 
Race and ethnicity 
Geography 
Hereditary 
The potential new risk factors  
Genotypes,  
Inflammatory markers 8,9 
         The potential predictors of risk of stroke and prognosis are inflammatory 
biomarkers like high sensitivity C-reactive protein and lipoprotein associated 
phospholipase A2.  Stroke can also be precipitated by infection.  Independent of 
lipid lowering effects in the drugs like statins decrease the levels of inflammatory 
biomarkers.  The ability of stating in reducing the stroke and coronary events has 
correlation with effect of statins on inflammatory biomarkers. 
12 
 
Functional markers10 
• Microalbuminuria 
        The increased thickness of tunica intima-media of common carotid artery is a 
result of microalbuminuria and atherosclerosis found in endothelial dysfunction.  
The most important screening test for finding the risk of atherosclerotic disease is 
the measurement of urinary microalbumin.  It is also used to determine the people 
who are prone for developing ischemic stroke. 
Etiology of ischemic stroke 
JP Mohr -  1997studied the various etiologies of stroke due to ischemia11 
• Embolism Cardiac or Aortic Origin migrating to brain 
o Myocardial Infarction12 
        One of the important complication of anterior wall MI is stroke.  It occurs in 
about 1 to 3% of all infarcts and in about 2 to 6% of patients with anterior wall MI.  
According to ECG studies in about 40% of anterior wall MI patients, left 
ventricular mural thrombosis occurs. Atrial fibrillation after AMI is an independent 
risk factor for stroke. 
o Atrial Fibrillation13  
         Cerebral infarction is as a result from embolization of intracardiac thrombi, 
mostly from the left atrial appendage.  The risk of recurrent stroke is very high in 
the first two weeks after the myocardial infarction. 
 
 
13 
 
 
o Disease of the heart valves14 
                 Ischemic stroke and cardiac valve disease has known association. 
Because embolism formed in native valves or prosthetic valves migrates and causes 
occlusion of blood vessels supplying brain. 
o Native Valves1 
                   Most common cause of thromboembolism is Rheumatic mitral stenosis.  
 
o Mitral Valve Prolapse16 
                Fibrinous deposits and endothelial denudation are seen in mitral valve 
prolapse.  Annular thrombus at the junction with atrial wall is also seen in Mitral 
valve prolapse.  Thromboembolic events are more formed in myxomatous and 
redundant valve leaflets. 
               Mitral stenosis and regurgitation, cardiac arrhythmias, abnormality in 
conduction and cardiogenic brain embolism are associated with calcifications of 
mitral annulus.  
 
o Cardiac Prosthetic Valves17 
              Tissue prosthetic valves has decreased risk of production 
thromboembolism when compared to the mechanical valves 
o Repaired Heart Valves18 
14 
 
               Percutaneous balloon valvuloplasty of  mitral valve is associated with risk 
of embolization,  the risk of stroke is approximately 2%. 
o  Aortic Arch Origin19 of emboli 
               Atherothrombotic or cholesterol embolism formed as a result of 
complicated atherosclerotic plaques in the aortic arch. 
o Patent Foramen Ovale20 
               The patent foramen ovale is a risk factor for stroke patient shown by  
de Belderet al . 
• Ischemia of brain due to reduced perfusion and Artery-to-Artery Embolism21- 
               Severe stenosis of carotid and basilar artery causes reduced perfusion 
leading to stroke. Micro stenosis of deep arteries also causes reduced perfusion. 
The most distal territories are affected prior to the most proximal territories which 
is termedas border zone(watershed infarction). 
o  Atherosclerotic Plaque in large arteries. 
               The most common cause of cerebral infarction associated with large 
cerebral artery plaques is artery to artery embolism. 
15 
 
o Vasculitis24,26 
               Inflammatory conditions like granulomatous angiitis, Giant cell arteritis, 
SLE(systemic lupus erythematosus), and polyarteritis nodosa are the conditions 
come under vasculitis.  
               The stroke mechanism alters like necrotizing vasculitis,  hypercoagulable 
state, artery-to-artery or cardiac embolism. In the arteria, inflammatory infiltration 
is seen in bacterial or tubercular meningitis paient, herpes zoster, arteritis, 
cysticercosis of brain and fungal infection. 
• Other arterial diseases 
o Occlusion24 of small arteries. 
               The small artery occlusion cause small ,deep lacunar or cavitory infarcts 
which forms the basic principle behind the small deep infarcts. The small arterial 
narrowing can cause focal zones of ischemic rarefaction –non cavitary , infarct of 
white matter or incomplete‐which are not true infarcts by histology 
o Intrinsic Small Artery Disease 
               The most common pathology in symptomatic lacunar infarcts is micro 
atheroma. In hypertensive patients the occlusion small penetrating arteries(less than 
200 μm ) is due to lipohyallinosis or segmental small arterial disorganization. This 
also leads to  small asymptomatic lacunar infarcts.  
16 
 
               Ischemic rarefaction and small deep cavitory infarcts are due to small 
granular arteriopathy associated with cerebral autosomal arteriopathy with 
subcortical infarct and leucoencephalopathy 11 
• Other Causes of occlusion of Small Vessel  
               The potential cause lacunar infarction is cardiogenic embolism. The first 
indication of critical large intracranial artery stenosis is lacunar syndrome. 
In the upper lateral borders of lateral ventricles, small deep infarcts are seen along 
with ipsilateral carotid occlusion in a deep watershed territory called as low flow or 
nternal water shed infarcts. 
               Hemodynamically significant cardiac disease other vasculitides and 
prothrombotic conditions  are risk factors for stroke 
o Prothrombotic States24 
Primary prothrombotic states  
• Antithrombins, heparin cofactor II,  
• Proteins C and S, and 
• Derangements of Fibrinolytic system.  
• Antiphospholipid antibodies  
 
Stroke Classifications 
TOAST Classification27 
Trial of Org 10172 in Acute Stroke Treatment (TOAST classification use most 
commonly  to subtype ischemic stroke . 
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TOAST classification categorize ischemic stroke based on etio-pathology. 
Etio-pathology of stroke was determined based on clinical examination, 
neuroimaging with CT or MRI, vascular imaging using angiography or ultrasound 
and cardiac investigations.   
Ischemic stroke patients are classified into following subgroups:  
1)  Atherosclerosis of large arteries.  
2) Cardio embolism,  
3) Occlusion of small vessels, 
  
4) Stroke of other determined etiology,  
5) Stroke of undetermined etiology, 
OCSP Classification 
OCSP classification describes the anatomical localization of infarct based on  
clinical subgroups 28,29 
Ischemic stroke is classified into following sub-groups:  
1) Total anterior circulation infarct (TACI),  
2) Partial anterior circulation infarct (PACI),  
3) Posterior cerebral infarct (POCI) and  
4) Lacunar infarct (LACI). 
The risk of stroke is double in patients with coronary artery disease.30  The 
attributable risk of stroke is about 12%.  
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Diabetes31 
The risk of stroke is independently related to diabetes. 
Dyslipidemia32 
The ischemic stroke is associated with increased serum triglycerides, total 
cholesterol and LDL cholesterol.   
Prognosis in Stroke Outcomes 
Stroke is the leading of long-term disability.  The case fatality rate in hemorrhagic 
stroke (33–45%) is higher than ischemic stroke (8–12%).  Men have higher age 
adjusted stroke mortality rates comparing to that of females. 33 
 
Clinical Diagnosis  
Clinical symptoms of ischemic stroke depend on the anatomical location of the 
thrombus. Stroke usually presents with an acute loss of brain functions. These 
functions usually involve the realm of motor, sensory, language, vision, visuo-
spatialperception or consciousness.  
A transient ischaemic attack, or TIA also known as “mini-stroke” or “warning 
stroke” in which symptoms of stroke are resolved within 24 hours.34 
ABCD2 score is useful in predicting the short-term stroke risk after a TIA35: 
A = Age  
B = Blood pressure  
C = Clinical symptoms  
D = Duration of symptoms  
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D = Diabetes. 
ABCD2 after a TIA 
Age 60>       Yes                         +1 
BP > 140/90 mmHg at initial evaluation      Yes      +1 
Clinical features of TIA: 
Unilateral weakness         +2  
Speech disturbance without weakness     +1 
Duration of symptoms?      10-59mins   +1 
                Over 60 mins          +2 
Diabetes mellitus in patient’s history?                Yes        +1 
HIGH RISK – score of 4 or above.  Should be consulted within 24 hours in a 
specialist TIA clinic. 
LOW RISK – any score of 3 or under 3.  Should be consulted within 7 days in a 
specialist TIA clinic. 
 
              Most ischemic strokes presents as a sudden loss of function in one of the 
domains.36   However, a sudden loss of neurological functions in the above domains 
could represent pathologies other than ischemic stroke. These include intracranial 
hemorrhage, seizures, vasovagal syncope, migraine, tumor, meningitis etc. Clinical 
examination along with neuroimaging secures a proper diagnosis of ischemic 
stroke. 
 
  
 
Figure 5: Function loss and domain relationship 
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           Figure 6: vascular territories  
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Treatment of acute ischemic stroke 
Stroke treatment was revolutionized with the introduction of tissue plasminogen 
activator for intravenous thrombolysis. 36 
Supportive therapy for acute ischemic stroke 
Supportive measures are very important in the acute phase factors such as high 
body temperature and high blood glucose may have deleterious effect on stroke  
outcome 37,38 
Neuroprotection 
Neuroprotection refers to the process of protecting neurons from apoptosis and 
ischemic degeneration. At present no neuroprotective agents are proven to have a 
definite effect in stroke patients.  
Components of stroke care unit.39 
In India implementation of stroke care unit is a big challenge and at present only 35 
stroke units are available.  Most of them were under the private sector. 
Thrombolysis  
Thrombolysis of stroke is a common practice in India.  
Rehabilitation  
Physiotherapists and speech therapists in India are mainly concerned with 
rehabilitation. 
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Drugs for secondary prevention 
Antiplatelet drugs, lipid lowering drugs should be initiated early for secondary 
stroke prevention.40 
Complications of stroke 41-46 
P Langhorne et.al in  2000in their study found the medical complications were as 
follows: 41 
• Neurological— 
o Recurrent stroke (9% of patients),  
o Epileptic seizure (3%);  
• Infections—42,43 
o Urinary tract infection (24%),  
o Chest infection (22%), 43 
o Others (19%);  
• Mobility related— 
o Falls (25%),  
o Falls with serious injury (5%),  
o Pressure sores (21%); 44 
• Thromboembolism— 
o Deep venous thrombosis (2%), 46 
o Pulmonary embolism (1%);  
• Pain— 
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o Shoulder pain (9%),  
o Other pain (34%); and  
• Psychological— 
o Depression (16%), 50 
o Anxiety (14%),  
o Emotionalism (12%), and  
o Confusion (56%).  
Prognosis in stroke 
Ischemic stroke subtypes have better prognosis as compared to stroke of cardio 
embolic stroke 51-53 
M Prencipe -  1998 54studied the minor ischemic strokes with minor or no disability 
by Rankin score and found that the 10-year mortality rate was 32%, with a relative 
risk of 1.7 (95% CI, 1.4 to 2.1) compared with the age- and sex-matched general 
population. Age, minor disability, myocardial infarction, non valvular atrial 
fibrillation and hypercholesterolemia increase the risk of disability and death, 
recurrent minor strokes. 
Hypertension has an association with death and stroke recurrence55.  Stroke 
recurrence is mainly predicted by the presence of hypertension in the Rochester 
study.56 
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MICROALBUMINURIA 
The mechanism of renal filtration of albumin  
Lazzara and Deen in 200757showed that through glomerular filtration membrane, 
albumin and protein reabsorbed in proximal convoluted tubule by receptor- 
mediated endocytosis. 
Birn et al. 58called the receptor complex called megalin-cubilin is involved in the 
endocytosis process. Albumin then undergoes degradation in the lysosome into 
amino acids which return to the blood stream. 
Microalbuminuria –definition 59 
30 - 300 mg per day level of albumin excreted is microalbuminuria (equivalent to 
20 to 200 µg/minute in a timed overnight urine collection, 20-200 mg/L on spot 
urine specimen or ACR 2.5 to 25 mg/mmol in males or 3.5 to 25 mg/mmol in 
females) 
In PREVEND study60 prevalence of microalbuminuria remains fairly constant for 
females, despite of their age group, but in males prevalence increases after the age 
of 50yrs.  In our study prevalence of microalbuminuria was higher in younger 
males as compared to older males(66.66% in males 50yrs of age). In the present 
study, the difference in occurrence of microalbuminuria were significant. 
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Category Spot Collection  Timed 
Collection  
24-hr Collection  
Normal Less than 30 
mcg/mg 
creatinine 
20 mcg/min 30-300 mcg/mg 
creatinine 
Microalbuminuria 30-300 mcg/mg 
creatinine 
20-200 mcg/min 30-300 mg 
Clinical 
albuminuria 
More than 300 
mcg/mg 
creatinine 
More than 200 
mcg/min 
More than 300 mg 
 
 
Table 1. American Diabetic Association Classification of Microalbuminuria61 
 
The various mechanisms underlying have been hypothesized  
In a study by Satchell 62 they reported that alteration of renal haemodynamics and 
endothelial changes is the mechanism underlying microalbuminuria that This 
process is also regulated by feedback mechanism of the afferent arteriole proposed 
by Helal  63 in 2012 and is  mediated by specific cells in the distal convoluted 
tubule when the volume of filtrate is high resulting in constriction of afferent 
arteriole to maintain GFR as shown by Mountokalakis, in 1997 64. 
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DallaVestra et al.65, 2003 said that the mechanism underlying microalbuminuriais 
was probably due to impairment of glomerular permeability. 
The various mechanisms underlying microalbuminuria proposed is the  
• Structural changes that allow passage of albumin in the urine in large quantities 
• Podocyte impairment  
• Impairment  in the glycocalyx   
• Functional impairment of the renin-angiotensin aldosterone system  
Angiotensin II is associated with increase in production of inflammatory mediators 
and reactive oxygen species which leads to sclerosis of podocytes. 
• Generalized endothelial dysfunction  
• Changes in the endothelial production of nitric  
• Renal hemodynamic abnormalities as a result of increased blood pressure may 
increase glomerular permeability.  
Microalbuminuria and disease 
In the recent time micro albuminemia has been proven to be associated with 
various diseases. 
• Garg and Bakris66 in their study microalbuminuria: marker of vascular 
dysfunction, risk factor for cardiovascular disease. 
• Monica Vermaa et al67showed that marker of disease activity in rheumatic 
arthritis is microalbuminuria. 
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• Hillege et al.68 conducted a cross-sectional cohort study in 2001 and reported the 
result.  According to that microalbuminuria (defined as 20-200 mg/L) was detected 
in 7.2% (n=2,918) of study subjects and independently associated with increased 
cardiovascular morbidity. 
• Van de Wal et al.69  evaluated patients with chronic heart failure with age of  69 ± 
12 years, and found that 32% of patients had microalbuminuria which is  higher 
than in the general population; 
• Molitch, Market.al 2010 .70 showed that prevalence of Diabetes is high in patients 
with microalbuminuria and lower eGFR. 
• Sharan Badiger et.al 71: Microalbuminuria in essential hypertension increases the 
risk of developing target organ damage. 
 
Detection of microalbuminuria  
As excretion of albumin exhibits high variability due to many confounders the 
diagnosis of microalbuminuria should be ideally based on screening of multiple 
samples using either 24-hour urine collection or first-morning voids. 
 The various methods available for checking the presence and levels of 
microalbuminuria. 
• Dipstick method  
Sarafidis et al., 200773 showed that microalbuminuria can be detected by dipstick 
method  
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• Poortmans76in his study showed the relationship between physical exercise as it 
increases urinary albumin excretion in normal individuals  
• There is an association of pregnancy and increase in urine albumin excretion 77 
• A reduction of dietary protein intake reduces microalbuminuria, as shown by 
Cohen et al78.  Similarly in long-term studies, changes in dietary protein correlate 
with changes in urinary albumin excretion as shown by Toeller, M., Buyken 
et.al79 
• Mogensen72showed that injection of dibasic amino acids acutely increases urinary 
albumin excretion. 
• Stressful situations increase albumin excretion 
• Carter, Joanne L., et al80stated that asymptomatic urinary tract infection increases 
albumin excretion. 
• Rosa, Tania Torres, and Paolo Palatini 81showed in essential hypertension 
urinary albumin excretion is directly proportional to the rise in BP values 
 
Studies on ischemic stroke and association with microalbuminuria 
In the J Chowdhury82 people aged inbetween 45-70 years were included.  86% of 
MA +ve, and 63% MA –ve group were in 60 years of age group.  63.3% are males 
and 36% were females in MA +ve group.  13.3% are females and 86.7% are males 
in MA –ve group.  The mean age and sex differences between MA +ve and MA –
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ve patients were not significant.  According to that study, mortality rate in MA +ve 
group was 26.7%  and that of MA –ve group is 11.7%. 
In Ghosh et al83 study (prospective), acute ischemic stroke patients(who were not 
diabetic) were included, and two more groups were formed by 60 healthy 
individuals whose age, sex were matched with 70 patients who had chronic 
neurological disease.  On day 1,4,7 they measured spot urinary albumin creatinine 
ratio in first morning sample.  61.79% of acute ischemic patients were MA +ve on 
day 1 when compared to 13% in non stroke neurological patients.  It was only 7% 
in healthy controls.   Patients with MA has 25-45% (high) 14 day disease specific 
mortality.  Patients without it has only 5.88% mortality. 
A study performed by Klausen84, that gave results that MA is associated with 
increased mortality in patients with cardiovascular diseases.  A timed overnight 
sample of urine were collected from 491 woman and men with coronary artery 
disease(age inbetween 30-80 years of age).  141 patients in that group died during 
the followup period.  The death risk associated with MA were univariate cox 
proportional hazards regression analysis.  2.0 was relative risk(p<0.001) of 
mortality in between the patient with UAE(Urinary Albumin Excretion) >5µg/min 
have high risk of death(100% high risk). 
Gumbnger et al.85did a study to know potential of microalbuminuria as a 
prognostic marker in patient with acute ischemic stroke and he concluded that 
microalbuminuria is a strong predictor of poor outcome. 
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Beamer et al.86 found that microalbuminuria is commonly found in patients with 
stroke and a main risk factor of stroke.  Though other risk factors were corrected. 
 
Lee et al.87 concluded microalbuminuria independent and strong association with 
stroke risk. Meng Lee, Jeffrey L Saver et al, did a meta analysis in Los Angeles, 
they identified 12 studies, with total of 48,598 participants 1263 stroke events. And 
concluded presence of microalbuminuria was associated with higher risk of  stroke 
after adjustment for cardiovascular risk factors are done. 
Sander et al.88 did a study on investigation of patients with ischemic stroke in 
neurological rehabilitation(INSIGHT).  
 A F Muhammedconducted a on patients of ischemic stroke, and found that micro 
albuminuria was present in 94(48.2%) patients and was absent in 101(51.8%) 
patients.89 
 
In M Heikki, study he found out that there is significant association between 
proteinuria (different degrees) and incidence of stroke in both the non diabetic and 
diabetic patients provided adjustment for cardiovascular risk factors were done.90 
Nancy Beamer, Bruce M Coull, Wayne M Clarke, Mike Wynn did a study in 
Portland in 1999, and found out that microalbuminuria was very much prevalent (3 
times) in patients with stroke(mainly in recent stroke). The prevalence of 
microalbuminuria was high in all major ischemic stroke subtypes i,e atheroembolic, 
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dioembolic and lacunar. Microalbuminuria was an independent significant risk 
factor of future CVA provided all other risk factors were    controlled 91. 
 
Farooq et al did a cross sectional study from 1st Apirl 2009 -30th sep 2009 to 
determine the frequency of microalbuminuria in patient with ischemic stroke. Out 
of the 195 patients of ischemic stroke studied microalbuminuria was present in  94 
and absent in 101.92 
 
Dirk Sander et al93, found that microalbuminuria has association with increase in 
thickness of intima and media of blood vessel wall, polyvascular disease, decrease 
in ankle brachial index. 
Nidhinandana  et al.94 did a study during Oct 2007- Jan 2008. He determined the 
association (relationship) between risk factors for ischemic stroke in 173 patents 
older than 25 years and concluded that diabetic mellitus and hypertension are one 
of the important factor for ischemic stroke associated with microalbuminuria. And 
in this diabetes is the most important factor  related to microalbuminuria in patients 
with ischemic stroke. 
Das et al.95 did a case control study from January 2008 to December 2010 about 
microalbuminuria as a risk for  ischaemic stroke using urine spot analysis.  31.7% 
of the patient had microalbuminuria.  But  8.3 % of the controls had that. 
Burton et al.96In 12 observational studies on 48,596 patients to know the 
relationship between microalbuminuria and overall stroke risk.  Meta-analysis of 
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that studies found out that there is 92% increase in risk of stroke in patient with 
microalbuminuria provided adjustment for other cardiovascular risk factors was 
done. 
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MATERIALS AND METHODS 
 
This study was a non-randomized cross sectional study done in medicine 
wards and IMCU of Sree Mookambika Institute of Medical Sciences, 
Kulasekharam during the 18 months study period on 50 ischemic stroke patients 
admitted and met pre-defined criteria gave informed consent for the study were 
chosen by convenient sampling technique.  The study was initiated after obtaining 
ethical clearance from the institutions ethical clearance committee. 
 
The Scientific basis of sample size used in the study was  
4Pq 
d2   where p=prevalence q=100-P d=20% of P 
Here   P=69     4*69(100-69)      =    8556 = 45 
(69 *20 100)2        190.44 
 
Even if the sample size is 45, for convinence 50 patients were studied. 
 
The criteria were  
a) Inclusion Criteria: 
 Patients with history of acute stroke presenting within 24 hours, confirmed by 
computer tomography of brain in SMIMS Kanyakumari, was included in the study. 
 Age more than 45 years 
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 Both Sex (Male & Female) 
 
b) Exclusion Criteria: 
 Patients who were not willing 
 Kidney diseases both acquired and congenital 
 Liver disease 
 Chronic inflammatory gastrointestinal disorder 
 Neoplasms 
 Those on NSAID’s or other immunosuppressant’s 
 Coronary artery disease or acute coronary event. 
 
After acceptation of the thesis by the ethics committee, 
An informed consent was obtained from all ischemic stroke patients who came to 
the IMCU and Medicine wards.  
A detailed general physical examination, Vitals and a detailed CNS examination 
was performed.  
Complete blood picture, Serum electrolytes, Blood urea, Random plasma glucose, 
FBS PPBS in case of diabetics, Serum creatinine, Fasting lipid profile, 
Electrocardiogram, Chest X-ray, CT scan brain- plain (contrast if needed)MRI 
brain (if indicated)2D echo (if indicated)Colour Doppler (if indicated) were  
obtained from case sheet. 
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 Then the urine albumin level of each patient was estimated and patients who were 
having urine albumin in microalbuminuric range and not having microalbuminuria 
are separated.  
 Then the strength of association of Microalbumunria in incidence of acute ischemic 
stroke was calculated and its association with risk factors estimated. 
 
Another objective of my study was to find relationship between 
microalbuminuria and subtype of stroke. For this, the CT finding of whether it is a 
Middle cerebral artery or Anterior cerebral artery or Posterior cerebral artery 
involvement was found out and its correlation with microalbuminuria was studied. 
 
• Sample collection and storage: 
Urine  samples was collected in autoclaved, dry, capped glass bottles. At least 10 
ml of random, midstream urine samples were collected from patients and 
centrifuged albumin as  centrifuged albumin can be stored 7 days @ 2-8oc 
 
• Laboratory investigations: 
A spot urine sample collected was centrifuged prior to testing.  
The Reagents A and B were used for assessment of urinary microalbumin levels 
kept at 2-8°C. Urine samples were subjected to analysis by the Latex Method for 
quantitative assessment of the amount of microalbumin (mg/L). This was done by a 
semi-automated biochemistry analyzer (Star 21 Plus).  
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Depending on urine albumin excretion, microalbuminuria (30-299µg/mg 
creatinine) was identified.  
All the investigations were carried out in the Central Laboratory, Sree 
Mookambika Institute of Medical Sciences, Kulasekharam  
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DATA AND STATISTICAL ANALYSIS 
All the data collected were in Microsoft Excel spread sheet. 
The data was expressed in MEAN±SD. Statistical Package for Social Sciences 
(SPSS 16.0) version used for analysis. Chi-square applied to find the statistical 
significant between the groups. P value less than 0.05 considered statistically 
significant at 95% confidence interval. 
Statistical Analysis was done using SPSS software version 23.0. In that statistical 
analysis, p value <0.05 is considered significant. 
 
 
ANALYSIS AND INTERPRETATIONS 
Non-randomized cross-sectional study done in the medicine wards and 
IMCU of Sree Mookambika Institute of Medical Sciences, Kulasekharam during 
the 18 months study period on 50 ischemic stroke patients admitted and met pre-
defined criteria.  These were our observations 
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DEMOGRAPHIC DATA 
AGE DISTRIBUTION 
AGE Frequency Percent
<44 2 4 
45-
50 
6 12 
51-
55 
6 12 
56-
60 
8 16 
61-
65 
5 10 
66-
70 
7 14 
71-
75 
7 14 
>75 9 18 
total  50 100 
 
Table 2: AGE DISTRIBUTION  
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Table 5: Systolic BP 
 
 
Systolic BP 
Valid frequency % Valid % Cumulative % 
 130 3 6.0 6.0 6.0 
140 5 10.0 10.0 16.0 
150 3 6.0 6.0 22.0 
160 7 14.0 14.0 36.0 
170 9 18.0 18.0 54.0 
180 15 30.0 30.0 84.0 
190 2 4.0 4.0 88.0 
200 6 12.0 12.0 100.0 
Total 50 100.0 100.0  
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Graph 4: Systolic BP 
Most of the patients were having Systolic blood pressure between 180-190 
mmHg. 
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Diastolic BP 
Valid frequency % Valid % Cumulative % 
 80 9 18.0 18.0 18.0 
90 16 32.0 32.0 50.0 
100 19 38.0 38.0 88.0 
110 6 12.0 12.0 100.0 
Total 50 100.0 100.0  
 
Table 6: Diastolic BP 
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Motor grade in affected limb 
  
Motor system power of 
affected limb 
Number Percentage (%)
Grade 0 8 16.00 
Grade 1 7 14.00 
Grade 2 7 14.0 
Grade 3 17* 34.00 
Grade 4 11 22.00 
(*p<0.05 significant compared score 3 with others) 
Table 10: Distribution of patients based on motor system power of affected limb 
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BIOCHEMICAL INVESTIGATION 
 
Biochemical investigation MEAN±SD 
RBS (mg/dl) 154.72±5.25 
Urea (mg/dl) 24.12±8.44 
Creatinine (mg/dl) 0.90±0.22 
Total cholesterol (mg/dl) 176.62±1.77 
Triglycerides (mg/dl) 128.12±1.92 
LDL 138.90±9.76 
HDL 63.36±9.51 
 
Table 11: Mean values of biochemical investigation  
 
 
 
 
 
 
  
    
In
sig
URIN
Urine m
Present 
Absent 
Table 
      Graph 
 our study, 
nificant co
E MICRO
icroalbum
(*p<0.0
12: Distribu
10: Distrib
74% of the
rrelation be
ALBUMIN
in 
5 significan
tion of pat
ution of pa
 patients ha
tween acut
Abse
(26.00
 
Num
37
13
t compared
ients based
tients base
d microalb
e ischaemi
nt 
%) 
ber 
 
* 
 present w
 on presenc
d on presen
uminuria a
c stroke an
Present 
(74.00 %) 
Per
ith absent) 
e of urine 
ce of urin
nd there w
d urine mic
centage 
(%) 
74.00 
26.00 
microalbum
 
e microalbu
as a statisti
roalbumin
54 
in 
min 
cally 
. 
  
38
pa
ECG s
EC
Presen
Absen
Table 
Graph
% of the p
tients with 
0
5
10
15
20
25
30
35
N
um
be
r 
howing LV
G(LVH) 
t 
t 
(*p<0.0
13: Distribu
 11: Distrib
atients had 
LVH whic
H 
5 significan
tion of pat
ution of pa
LVH.  The
h was statis
Present
Numbe
19
31*
t compared
ients based
tients based
re was hig
tically prov
r 
 present w
 on ECG (L
 on ECG (
her inciden
en. 
Perce
(%
38
62
ith absent) 
VH) chan
LVH) chan
ce of micr
Absent
ntage 
) 
.00 
.00 
ges 
ges 
oalbuminur
55 
 
ia in 
56 
 
 
TERRITORY OF BRAIN INFARCT 
Territory Number Percentage 
(%) 
MCA 32 64.00 
PCA 10 20.00 
ACA 8 16.00 
 
Table 14: Distribution of patients based on territory 
Of the 50 patients with acute ischaemic stroke 32 had MCA infarct which accounts 
for 64%. 
 
 
 
 
 
 
 
57 
 
Microalbunuria MCA ACA PCA 
Number Percentage 
(%) 
Number Percentage 
(%) 
Number Percentage 
(%) 
Present 20 62.50 7 87.50 10 100.00 
Absent 12* 37.50 1* 12.50 0* 00.00 
Total 32 100.00 8 100.00 10 100.00 
(*p<0.05 significant compared Present with Absent) 
Table 15: Distribution of patients based on microalbuminuria in relation to territory 
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AGE DISTRIBUTION 
 
Microalbuminuria 
30-50 years 51-70 years 71-90 years 
Number Percentage 
(%) 
Number Percentage 
(%) 
Number Percentage 
(%) 
Present 6 75.00 18 69.23 13 81.25 
Absent 2 25.00 8 30.77 3 18.75 
Total 8 100.00 26 100.00 16 100.00 
 
Table 16: Distribution of patients based on microalbuminuria in relation to age 
 The mean age of the patients were 51 to 70 years.  There was no significant 
correlation microalbuminuria with particular age group.  
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GENDER DISTRIBUTION 
Microalbuminn
uria 
Male Female  
Num
ber 
Percent
age (%) 
Num
ber 
Percent
age (%) 
Present 18 72.00 19 76.00 
Absent 7 28.00 6 24.00 
Total 25 100.00 25 100.00 
 
Table 17: Distribution of patients based on microalbuminuria in relation to gender 
 In our study, 25 males and 25 females were taken.  There was no significant 
correlation between microalbuminuria and gender. 
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PULSE RATE AND BLOOD PRESSURE 
 
Microalbunuria Pulse rate 
(MEAN±SD)
SBP 
(MEAN±SD)
DBP 
(MEAN±SD) 
Present 74.18±1.08  175.95±1.46* 97.02±8.11* 
Absent 77.23±4.86  150.77±2.06  86.92±8.54 
                         (*p<0.05 significant compared Present with Absent) 
 
Table 18: Blood pressure in patients with and without microalbuminuria 
 The average systolic blood pressure of the patients with microalbuminuria 
was 175.95±1.46.  There was significant correlation of microalbuminuria with 
elevated blood pressure. 
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BLOOD SUGAR 
Microalbunuria RBS (MEAN±SD) 
Present 151.95±4.84* 
Absent 162.62±6.43 
(*p<0.05 significant compared Present with Absent) 
Table 19: Blood sugar in patients with and without microalbuminuria 
 There was significant association of microalbuminuria with elevated blood 
sugar levels. 
LIPID PROFILE 
Microalbunuria Total 
Cholesterol 
(MEAN±SD)
Triglycerides 
(MEAN±SD)
LDL 
(MEAN±SD) 
HDL 
(MEAN±SD)
Present 176.03±1.59* 127.16±2.05* 137.73±1.07*  61.70±8.39
Absent 178.31±2.28 130.85±1.54 140.69±7.56 69.07±1.06
(*p<0.05 significant compared Present with Absent) 
Table 20: Lipid profile in patients with and without microalbuminuria 
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RENAL FUNCTION 
Microalbunuria Creatinine (MEAN±SD) 
Present 0.92±0.21*
Absent 0.86±0.23
(*p<0.05 significant compared Present with Absent) 
Table 21: Creatinine levels in patients with and without microalbuminuria 
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DISCUSSION 
With the increasing life expectancy and increase in the modifiable and     
non-modifiable risk factors, there has been an upsurge in the non-communicable 
diseases  among them stroke is considered as diseases that  has to be identified 
early or if possible be prevented so that the disability related it is reduced.  Micro 
albuminuria is considered as a manifestation of a generalized disorder and its role 
in early prediction of various studies has been well documented .we conducted a 
study titled “A STUDY ON MICROALBUMINURIA IN ACUTE ISCHEMIC 
STROKE PATIENTS” which was done as a non-randomized cross sectional study 
in the medicine wards and IMCU of Sree Mookambika Institute of Medical 
Sciences, Kulasekharam for 18 months study period on 50 ischemic stroke patients 
admitted and met pre-defined criteria gave informed consent after obtaining ethical 
clearance from the institutions ethical clearance committee. 
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Urine 
microalbumin 
Systolic 
BP 
Diastolic 
BP GCS 
CN. 
Involved/ 
not 
which 
nerve 
Motor 
system RBS(mg/dl Creatinine TC/ TG
Pearson 
Correlation 
.624** .420** .092 .350* -.350* -.260 .181 .106 -.110 
Sig. (2-tailed) .000 .002 .524 .013 .013 .069 .208 .462 .448 
N 50 50 50 50 50 50 50 50 50 
 
 
Table 22: correlations of microalbuminuria with various parameters  
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Correlation of microalbuminuria with age,  
The mean age in our study most of the patients were in the age of 51 to 70 
years 
There was  no statistically significant correlation of microalbuminuria with age.  
It is in correlation with the study done by Jarrett.et al 97and Dogra et.al 98who found 
no statistically significant correlation of microalbuminuria with age 
In our study we found as the age advances the chances of stroke increase as in  the 
study by  Subramanyam 99who found statistically significant correlation between 
increasing age in ischemic stroke  
 
Correlation of microalbuminuria with gender,  
There was a no correlation of microalbuminuria with gender. 
It is in correlation with the study done by Chowta et.al 36who found no statistically 
significant correlation of microalbuminuria with gender. 
In our study we found that the both male and female gender has equal risk for 
chances of stroke.  It is comparable with the study done by Subramanyam99 who 
found statistically significant correlation of gender with ischemic stroke.  
    Total no. of patients in study: 50 
            No. of male patients      : 25 
            No. of female patients   : 25 
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• Rosa, Tania Torres, and Paolo Palatini 81showed in essential hypertension 
urinary albumin excretion is directly proportional to the rise in BP values 
• In the Danish MONICA100 project showed that among the hypertensive subjects 
who developed future ischaemic disease the prevalence of microalbuminuria was 
higher.  
• Sharan Badiger et.al 101: Microalbuminuria in essential hypertension increases the 
risk of developing target organ damage 
 
Correlation of microalbuminuria with RBS,  
 There positive correlation of microalbuminuria with the level of sugars in 37 
patients who had an evidence of  albumin in urine  10 had compared glucose 
tolerance and 26 had diabetes mellitus.   
In our study, the total number of acute ischaemic stroke patients was 50 and 
the mean RBS value was 151.95±4.84 and there was significant correlation 
between microalbuminuria and blood sugar level. 
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• Molitch, Market.al 2010 103 showed that microalbuminuria +ve patients have high 
prevalence of diabetes & lower eGFR value. 
Correlation of microalbuminuria with ECg finidings  
• Berton et al96showed the  importance of microalbuminuria as prognostic factor for 
short and long-term outcomes of acute myocardial infarction  
• Koulouris et al., 2005104 and Apostolovic et al., 2011105showed that increased 
urinary excretion of albumin was a strong predictor for  myocardial infarction 
complications including mortality.  
• ECG images from 7579 PREVEND participants who were not diabetic revealed an 
independent relationship between microalbuminuria and infarct patterns (odds ratio 
[OR] 1.61; 95% CI 1.12 to 2.32), major ischemia (OR 1.43; 95% CI 1.08 to 1.91), 
and minor ischemia (OR 1.32; 95% CI 1.03 to 1.68106 
Correlation of microalbuminuria with lipid profile 
 In our study, no. of acute ischaemic stroke patients: 50 
                          Mean value for total cholesterol      : 176.03±1.59 
                          Mean value for triglycerides            : 127.16±2.05 
                          Mean value for LDL                        : 137.73±1.07 
                    There was statistically significant correlation between 
microalbuminuria and lipid profile. 
 Chowdhury et al in their study found a positive Correlation between 
microalbuminuria & lipid profile in acute ischemic stroke which is comparable to 
our study 82 
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In our study of 50 patients with acute ischaemic stroke, microalbuminuria 
was found equally in all three vascular territories(MCA, ACA and PCA).  Thus, 
there was no significant correlation of microalbuminuria with particular vascular 
territory. 
 
 
 
 
 
Coefficients 
 
 
 
 
Unstandardized 
Coefficients 
Standardize
d 
Coefficients
T Sig. B Std. Error Beta
Territory    
(1-MCA/2-
ACA/3-PCA) 
. 
194 
 
.074 
 
.356 
 
2.641 
 
.011 
(Constant) .437 .129  3.383 .001 
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RESULTS 
In our study titled ‘A STUDY ON MICRO ALBUMINURIA IN ACUTE 
ISCHEMIC STROKE PATIENTS’ 50 cases of acute ischemic stroke patients were 
taken. 
Among the 50 patients, most of the patients come under the age of 51 to 70 
years(52%).  There was no statistically significant correlation of microalbuminuria 
with age.  
There were 25 male and 25 female participated in the study.  We found that 
the both male and female gender had equal risk for chances of stroke. 
In our study, we found that the prevalence of microalbuminuria in patient 
with acute ischemic stroke was 74% and there was significant correlation between 
microalbuminuria and stroke.  Thus we concluded that there was a strong possible 
relation of microalbuminuria as a risk factor for stroke. 
 The cranial nerve involvement was seen in about 32 patients(64%) of all the 
50 patients.  There was a significant correlation of facial nerve involvement(32 
cases-64%) with acute ischaemic stroke than other cranial nerves. 
The most common vascular territory involved was MCA about 64%.  In our 
study of 50 patients with acute ischaemic stroke, microalbuminuria was found 
equally in all three vascular territories(MCA, ACA and PCA).  Thus, there was no 
significant correlation of microalbuminuria with particular vascular territory. 
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38% of the patients had LVH.  There was higher incidence of 
microalbuminuria in patients with LVH which was statistically proven. 
In our study of 50 patients with acute ischemic stroke, most of the patients 
had a systolic blood pressure of 180-190 mmHg and diastolic blood pressure 
between 90-110 mmHg. There was a positive  correlation of microalbuminuria with  
Systolic BP and Diastolic BP.   
There was statistically significant correlation between microalbuminuria and 
lipid profile. 
There was significant correlation between microalbuminuria and blood 
sugar level. 
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CONCLUSION 
In our study titled “A STUDY ON MICROALBUMINURIA IN ACUTE 
ISCHEMIC STROKE PATIENTS” we found that  
- the prevalence of microalbuminuria in patients with acute ischemic stroke was 
74%. there was a strong positive relationship of microalbuminuria as an important 
independent  risk factor for stroke. Significant correlation between various risk 
factors of ischemic stroke such as hyperglycemia, hypertension, hyperlipidemia 
with microalbuminuria has established. Eventhough microalbuminuria was present 
in 74% of my study, no significant association of microalbuminuria with particular 
vascular territory has noted. But we recommend that larger trials and long term 
follow up studies be conducted 
 
DRAWBACKS: 
• Small group taken into study. 
• Long term follow-up have not conducted. 
• Only spot examination of the blood sugar and blood pressure are noted. 
• Though hyperglycemia and hypertension are one of the causes of 
microalbuminuria, patients with these diseases are not excluded in this study. 
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SUMMARY 
 
We conducted a study titled “A STUDY ON MICROALBUMINURIA IN 
ACUTE ISCHEMIC STROKE PATIENTS” which was done as a non-randomized 
cross sectional study in the medicine wards and IMCU of Sree Mookambika 
Institute of Medical Sciences, Kulasekharam for 18 months study period on 50 
ischemic stroke patients admitted and met pre-defined criteria gave informed 
consent after obtaining ethical clearance from the institutions ethical clearance 
committee. 
In our study of 50 patients with ischaemic stroke, 74% had significant 
microalbuminuria.  MCA was the most common territory involved with 64% cases 
followed by PCA in 10 % and ACA IN 8%.  But no significant correlation of 
microalbuminuria with particular vascular territory has found out.  In our study 62 
% cases had ECG showing LVH pattern. crainal nerve involvement most 
commonly facial nerve was seen in 64% of all cases. There was a positive co-
relation between lipid profile and LVH with microalbuminuria .  There is 
statistically significant co-relation between elevated blood sugar and elevated blood 
pressure in patients admitted with ischemic stroke less than 24hours. There was 
strong positive relationship of microalbuminuria in acute ischemic stroke patients 
and microalbuminuria is an important independent  risk factor for stroke. 
  
76 
 
BIBLIOGRAPHY 
 
REFERENCES 
 
1.  Cotran RS, Kumar V, Fausto N, Nelso F, Robbins SL, Abbas AK. Robbins and 
Cotran pathologicbasis of disease. 7th ed. St. Louis, Mo: Elsevier Saunders; 2005. 
p. 739-42. 
2. Dalal P, Bhattacharjee, Vairale J, Bhat P. Mumbai stroke registry (2005-6)-
Surveillance usingWHO STEPS stroke instrument- challenges and opportunities. J 
Assoc Physcian India 2008;56:675-9. 
3. Sacco RL, Benjamin EJ, Broderick JP, Dyken M, Easton JD, Feinberg WM, et al. 
American HeartAssociation Prevention Conference. IV. Preventionand 
Rehabilitation of Stroke. Risk factors. Stroke 1997;28:1507-17. 
4. Feigin V, Lawes C, Bennet D, Barker CS, Parag V. Worldwide stroke incidence 
and early case fatalityin 56 population based studies: a systematic review. Lancet 
Neurol 2009;8:355- 69. 
5. Gupta R, Joshi P, Mohan V, Reddy S, Yusuf S. Epidemiology and causation of 
coronary heart disease andstroke in India. Heart 2008;94:16-26. 
6. Dalal P, Bhattacharjee M, Vairale J, Bhat P. UN millennium development goals: 
can we halt thestroke epidemic in India?Ann Indian Acad Neurol 2007;10:130-6. 
77 
 
7. Pandian J . Public awareness of warning symptoms, risk factors and treatment of 
stroke in Northwest India. Stroke 2005;36:644-8. 
8. Viberti GC, Jarrett RJ, Keen H. Microalbuminuria as prediction of nephropathy in 
diabetics. Lancet 1982;11:611. 
9. Bennett PH, Haffner S, Kasiske BL . Screening and management of 
microalbuminuriain patients with diabetes mellitus: recommendations to the 
Scientific Advisory Board of theNational Kidney Foundation from an ad hoc 
committee of the Council on Diabetes Mellitusof the National Kidney Foundation. 
Am J Kidney Dis 1995;25:107–12. 
10. Rocco A, Heerlein K, Diedler J . Microalbuminuria in cerebrovascular disease: a 
modifiable risk factor? Int J Stroke 2010;5:30–4. 
11. Schmitz A. Microalbuminuria, blood pressure, metabolic control, and renal 
involvement:longitudinal studies in white non-insulin-dependent diabetic patients. 
Am J Hypertension 1997;10:189S–97S 
12. Deckert T, Kofoed-Enevoldsen A, Norgaard K . Microalbuminuria. Implications 
formicro- and macrovascular disease. Diabetes Care 1992;15:1181–91. 
13.  WHO in collaboration with the US Centers for DiseaseControl and Prevention: 
The Atlas of Heart Disease andStroke. Global Burden of Stroke. Available at: 
http://www.who.int/cardiovascular_diseases/resources/atlas/en/index.html 
14.    Valmadrid CT, Klein R, Moss SE, Klein BE. The risk of cardiovascular disease 
mortality associated with microalbuminuria and gross proteinuria in persons with 
older-onset diabetes mellitus.Arch Intern Med 2000;160:1093-100. 
78 
 
15.  Miettinen H, Haffner SM, Lehto S, Ronnemaa T, PyoralaK, Laakso M. 
Proteinuria predicts stroke and other atherosclerotic vascular disease events in 
nondiabetic and non-insulin dependent diabetic subjects. Stroke 1996;27:2033-9. 
16.  Madison JR, Spies C, Schatz IJ. Proteinuria and risk for stroke and coronary heart 
disease during 27 years of follow-up: the Honolulu Heart Program. Arch Intern 
Med 2006;166:884-9. 
17.  Irie F, Iso H, Sairenchi T . The relationships of proteinuria, serum creatinine, 
glomerular filtration rate with cardiovascular disease mortality in Japanese general 
population. Kidney Int 2006;69:1264-71. 
18.  Nakayama T, Date C, Yokoyama T, Yoshiike N,Yamaguchi M, Tanaka H. A 
15.5-year follow-up study of stroke in a Japanese provincial city: The Shibata 
Study.Stroke 1997;28:45-52. 
19.  Sasaki A, Horiuchi N, Hasegawa K, Uehara M. Mortality from coronary heart 
disease and cerebrovascular disease andassociated risk factors in diabetic patients 
in Osaka District, Japan. Diabetes Res Clin Pract 1995;27:77-83. 
20.  Wagner DK, Harris T, Madans JH. Proteinuria as a biomarker:Risk of subsequent 
morbidity and mortality. Environ Res 1994;66:160-72. 
21. Beamer NB, Coull BM, Clark WM. From the department of neurology Arzona 
Health Science Centre Tucson (Ms Beamer & Dr Call) and orange Health Science 
University Portland. Arch Neurol 1999;56:699-702. 
79 
 
22. Chowdary J, Sultan N,Ahmed S, Rahman MM, Akter M, Rafique T. 
Microalbuminuria as a predictor of short term mortality in acute ischemic stroke. 
Bangladesh J Med Biochem 2012;5:16-9. 
23. Gumbinger C, Sykora M, Diedler J, Ringleb P, Rocco A. Microalbuminuria a 
potential prognostic marker for acute stroke  Nervenarzt 2012;83:1357-60.  
24.  Menglee, Jeffrey, I SAver, Kuo hasuan chang,Bruce orbigale (levels of 
albuminuria risk of stroke systemic review and meta analysis and paper on 
cerebrovascular disease.AHA J 2010;30;464-69. 
25. Sander D, Weimar C, Bramlage P, Brandt T, Siebler RLM. MIcroalbuminuria 
indicates long term vascular risk in patirnts after acute stroke undergoing in 
patients rehabilitation.. BMC Neurol 2012;2:2377-102.  
26. Muhammed AF, Muhammad SA, Fayyaz MA, Naila K. Frequency of 
microalbuminuria in patients with ischemic stroke. Rawal Med  J 2013;38:97-9. 
27.  Verdon C, Barzi F, Cass A, Gallagher M, Jardine M, Perkovic TNV et al. Am J 
Kidney Dis 2009;53:417-25. 
28.  Nidhinandana SR, Napasrichaisinanunkul. The association between risk factors 
for ischemic stroke and microalbuminuria. J Med Assoc Thai 2010:555-9. 
29.  Das P, Bhulyann MM, Mia BA, Ullah MA, Alarm SM, Sheik AK et al. Urinary 
microalbuminuria as a risk factor for ischaemic stroke. Mymensingh Med J 2012: 
709-14. 
30. Burton K. Microalbuminuria a strong stroke risk. European Heart J 2009;30:1364-
71. 
80 
 
31. Bingham S, Day NE, Welch A, Luben R, Khaw T, Yuyun MF. Microalbuminuria 
and stroke in a British population: the European Prospective Investigation into 
CancerNorflok(EPIC-Norfolk) population study. J Intern Med 2004;255:247-56. 
32. Willey JZ, Xu Q, Boden-Albala B, Paik MC, Moon YP, Sacco RL, Elkind 
MS. Lipid profile components and risk of ischemic stroke: the Northern 
Manhattan Study (NOMAS). Archives of neurology. 2009 Nov 
9;66(11):1400-6. 
33. Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, 
Flegal K, Ford E, Furie K, Go A, Greenlund K, Haase N. Heart disease and 
stroke statistics—2009 update a report from the American Heart 
Association Statistics Committee and Stroke Statistics Subcommittee. 
Circulation. 2009 Jan 27;119(3):e21-181. 
34. Cucchiara B, Kasner SE. Transient Ischemic Attack. Annals of internal 
medicine. 2011 Jan 4;154(1):ITC1-1. 
35. Josephson SA, Sidney S, Pham TN, Bernstein AL, Johnston SC. Higher 
ABCD2 score predicts patients most likely to have true transient ischemic 
attack. Stroke. 2008 Nov 1;39(11):3096-8. 
36. Schellinger PD, Jansen O, Fiebach JB, Heiland S, Steiner T, Schwab S, 
Pohlers O, Ryssel H, Sartor K, Hacke W. Monitoring intravenous 
recombinant tissue plasminogen activator thrombolysis for acute ischemic 
stroke with diffusion and perfusion MRI. Stroke. 2000 Jun 1;31(6):1318-28. 
81 
 
37. Meden P, Overgaard K, Pedersen H, Boysen G. The influence of body 
temperature on infarct volume and thrombolytic therapy in a rat embolic 
stroke model. Brain research. 1994 May 30;647(1):131-8. 
38. Dietrich WD, Bramlett HM. Hyperthermia and central nervous system 
injury. Progress in brain research. 2007 Dec 31;162:201-17. 
39. Langhorne P, Pollock A. What are the components of effective stroke unit 
care?. Age and Ageing. 2002 Sep 1;31(5):365-71. 
40. Amarenco P, Labreuche J, Lavallée P, Touboul PJ. Statins in stroke 
prevention and carotid atherosclerosis systematic review and up-to-date 
meta-analysis. Stroke. 2004 Dec 1;35(12):2902-9. 
41. Langhorne P, Stott DJ, Robertson L, MacDonald J, Jones L, McAlpine C, 
Dick F, Taylor GS, Murray G. Medical complications after stroke a 
multicenter study. Stroke. 2000 Jun 1;31(6):1223-9. 
42. Kalra L, Yu G, Wilson K, Roots P. Medical complications during stroke 
rehabilitation. Stroke. 1995 Jun 1;26(6):990-4. 
43. Holas MA, DePippo KL, Reding MJ. Aspiration and relative risk of medical 
complications following stroke. Archives of Neurology. 1994 Oct 
1;51(10):1051-3. 
44. Davenport RJ, Dennis MS, Wellwood I, Warlow CP. Complications after 
acute stroke. Stroke. 1996 Mar 1;27(3):415-20. 
82 
 
45. Doshi VS, Say JH, Young SH, Doraisamy P. Complications in stroke 
patients: a study carried out at the Rehabilitation Medicine Service, Changi 
General Hospital. Singapore Med J. 2003 Dec;44(12):643-52. 
46. Kumar S, Selim MH, Caplan LR. Medical complications after stroke. The 
Lancet Neurology. 2010 Jan 31;9(1):105-18. 
47. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress 
hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients 
a systematic overview. Stroke. 2001 Oct 1;32(10):2426-32 
48. Frankel MR, Morgenstern LB, Kwiatkowski T, Lu M, Tilley BC, Broderick 
JP, Libman R, Levine SR, Brott T. Predicting prognosis after stroke A 
placebo group analysis from the National Institute of Neurological 
Disorders and Stroke rt-PA Stroke Trial. Neurology. 2000 Oct 
10;55(7):952-9.. 
49. Lindgren I, Jönsson AC, Norrving B, Lindgren A. Shoulder pain after stroke 
A prospective population-based study. Stroke. 2007 Feb 1;38(2):343-8. 
50. Kotila M, Numminen H, Waltimo O, Kaste M. Depression after stroke 
results of the finnstroke study. Stroke. 1998 Feb 1;29(2):368-72. 
51. Adams RJ, Chimowitz MI, Alpert JS, Awad IA, Cerqueria MD, Fayad P, 
Taubert KA. Coronary risk evaluation in patients with transient ischemic 
attack and ischemic stroke a scientific statement for healthcare 
professionals from the stroke council and the council on clinical cardiology 
83 
 
of the american heart association/american stroke association. Circulation. 
2003 Sep 9;108(10):1278-90. 
52. Norrving B. Long-term prognosis after lacunar infarction. The Lancet 
Neurology. 2003 Apr 30;2(4):238-45. 
53. Rockwood K. Vascular cognitive impairment and vascular dementia. 
Journal of the neurological sciences. 2002 Nov 15;203:23-7. 
54. Prencipe M, Culasso F, Rasura M, Anzini A, Beccia M, Cao M, Giubilei F, 
Fieschi C. Long-Term prognosis after a minor stroke 10-year mortality and 
major stroke recurrence rates in a hospital-based cohort. Stroke. 1998 Jan 
1;29(1):126-32.  
55. Lai SM, Alter M, Friday G, Sobel E. A multifactorial analysis of risk factors 
for recurrence of ischemic stroke. Stroke. 1994 May 1;25(5):958-62. 
56. Willmot M, Leonardi-Bee J, Bath PM. High blood pressure in acute stroke 
and subsequent outcome a systematic review. Hypertension. 2004 Jan 
1;43(1):18-24. 
57. Lazzara MJ, Deen WM. Model of albumin  reabsorption  in  the proximal  tubule. 
American Journal of Physiology‐Renal Physiology. 2007 Jan 1;292(1):F430‐9. 
58. Christensen EI, Birn H, Verroust P, Moestrup SK. Membrane receptors for 
endocytosis in the renal proximal tubule. Int Rev Cytol 1998; 180: 237–284 
59. Toto RD. Microalbuminuria: definition, detection, and clinical significance. The 
journal of clinical hypertension. 2004 Nov 1;6(s11):2-7. 
84 
 
60. Atthobari, J., Asselbergs, F.W., Boersma, C., de Vries, R., Hillege, H.L., van 
Gilst, W.H., Gansevoort, R.T., de Jong, P.E., Postma, M.J. and PREVEND IT 
Study Group, 2006. Cost-effectiveness of screening for albuminuria with 
subsequent fosinopril treatment to prevent cardiovascular events: A 
pharmacoeconomic analysis linked to the prevention of renal and vascular 
endstage disease (PREVEND) study and the prevention of renal and vascular 
endstage disease intervention trial (PREVEND IT). Clinical therapeutics, 28(3), 
pp.432-444. 
61. Foster MC, Hwang SJ, Larson MG, Parikh NI, Meigs JB, Vasan RS, Wang TJ, 
Levy D, Fox CS. Cross-classification of microalbuminuria and reduced glomerular 
filtration rate: associations between cardiovascular disease risk factors and clinical 
outcomes. Archives of internal medicine. 2007 Jul 9;167(13):1386-92. 
62. Satchell SC, Tooke JE. What is the mechanism of microalbuminuria in diabetes: a 
role for the glomerular endothelium?. Diabetologia. 2008 May 1;51(5):714-25. 
63. Helal I, Fick-Brosnahan GM, Reed-Gitomer B, Schrier RW. Glomerular 
hyperfiltration: definitions, mechanisms and clinical implications. Nature Reviews 
Nephrology. 2012 May 1;8(5):293-300. 
64. Mountokalakis TD. The renal consequences of arterial hypertension. Kidney 
international. 1997 May 31;51(5):1639-53. 
65. Dalla Vestra M, Masiero A, Roiter AM, Saller A, Crepaldi G, Fioretto P. Is 
podocyte injury relevant in diabetic nephropathy? Studies in patients with type 2 
diabetes. Diabetes. 2003 Apr 1;52(4):1031-5. 
85 
 
66. Garg JP, Bakris GL. Microalbuminuria: marker of vascular dysfunction, risk 
factor for cardiovascular disease. Vascular medicine. 2002 Feb 1;7(1):35-43. 
67. Verma M, Shanker V, Singh H, Soni A, Madaan H, Singh J. Microalbuminuria: A 
marker of severe disease activity in rheumatoid arthritis. Indian Journal of 
Rheumatology. 2013 Sep 30;8(3):112-6. 
68. Hillege HL, Fidler V, Diercks GF, van Gilst WH, de Zeeuw D, van Veldhuisen 
DJ, Gans RO, Janssen WM, Grobbee DE, de Jong PE. Urinary albumin excretion 
predicts cardiovascular and noncardiovascular mortality in general population. 
Circulation. 2002 Oct 1;106(14):1777-82. 
69. van de Wal RM, Asselbergs FW, Plokker HT, Smilde TD, Lok D, van Veldhuisen 
DJ, van Gilst WH, Voors AA. High prevalence of microalbuminuria in chronic 
heart failure patients. Journal of cardiac failure. 2005 Oct 31;11(8):602-6. 
70. Molitch ME, Steffes M, Sun W, Rutledge B, Cleary P, De Boer IH, Zinman B, 
Lachin J. Development and progression of renal insufficiency with and without 
albuminuria in adults with type 1 diabetes in the diabetes control and 
complications trial and the epidemiology of diabetes interventions and 
complications study. Diabetes care. 2010 Jul 1;33(7):1536-43. 
71. Badiger S, Akkasaligar PT, Sandeep HM, Biradar MS. Microalbuminuria in 
Essential Hypertension. World Academy of Science, Engineering and Technology, 
International Journal of Medical, Health, Biomedical, Bioengineering and 
Pharmaceutical Engineering. 2011 Dec 20;5(12):716-20. 
87 
 
79. Toeller M, Buyken A, Heitkamp G, Brämswig S, Mann J, Milne R, Gries FA, 
Keen H, EURODIAB IDDM Complications Study Group. Protein intake and 
urinary albumin excretion rates in the EURODIAB IDDM Complications Study. 
Diabetologia. 1997 Sep 1;40(10):1219-26. 
80. Carter JL, Tomson CR, Stevens PE, Lamb EJ. Does urinary tract infection cause 
proteinuria or microalbuminuria? A systematic review. Nephrology Dialysis 
Transplantation. 2006 Nov 1;21(11):3031-7. 
81. Rosa TT, Palatini P. Clinical value of microalbuminuria in hypertension. Journal 
of hypertension. 2000 Jun 1;18(6):645-54 
82. Chowdhury J, Sultana N, Ahmed S, Rahman MM, Akter M, Rafique T. 
Microalbuminuria as a Predictor of Short-Term Mortality in Acute Ischemic 
Stroke. Bangladesh Journal of Medical Biochemistry. 2013 Jan 20;5(1): 
16-9. 
83. Ghosh S, Bandyopadhyay SK, Bandyopadhyay R, Sarkar N. Micro-
albuminuria: a predictor of short-term mortality in acute ischaemic stroke. 
Journal of the Indian Medical Association. 2008 Dec;106(12):783-4. 
84. Klausen K, Borch-Johnsen K, Feldt-Rasmussen B, Jensen G, Clausen P, Scharling 
H, Appleyard M, Jensen JS. Very low levels of microalbuminuria are associated 
with increased risk of coronary heart disease and death independently of renal 
function, hypertension, and diabetes. Circulation. 2004 Jul 6;110(1):    32-5.  
85. Gumbinger C, Sykora M, Diedler J, Ringleb P, Rocco A. Microalbuminuria. 
Der Nervenarzt. 2012 Oct 1;83(10):1357-60. 
88 
 
86. Beamer NB, Coull BM, Clark WM, Wynn M. Microalbuminuria in ischemic 
stroke. Archives of neurology. 1999 Jun 1;56(6):699-702. 
87. Lee M, Saver JL, Chang KH, Liao HW, Chang SC, Ovbiagele B. Low 
glomerular filtration rate and risk of stroke: meta-analysis. Bmj. 2010 Sep 
30;341:c4249. 
88. Sander D, Weimar C, Bramlage P, Brandt T, Rosin L, Siebler M. 
Microalbuminuria indicates long-term vascular risk in patients after acute 
stroke undergoing in-patient rehabilitation. BMC neurology. 2012 Sep 
24;12(1):1. 
89. Muhammed AF,Muhammad SA,Fayyaz MA ,Naila K. Frequency of 
microalbuminuria in patients with ischemic stroke. Rawal Medical Journal. 2013; 
38(2): 97-9. 
90.   M Heikki, M Stevens et al. Protreinuria Predicts Stroke and Other 
Atherosclerotic Vascular Disease Events in Nondiabetic and Non Insulin 
Dependent Diabetic Subjects; American stroke association journal.Nov 
1996;27(11). 
91. B B Nancy, M C Bruce, M C Wayne, Wynn Mike. Microalbuminuria in Ischemic 
Stroke. Arch Neurol Journal.June 1999;56:699-702 
92. Farooq MA, Anjum MS, Malik FA, Kalsoom N. Frequency of 
microalbuminuria in patients with ischemic stroke. Rawal Medical Journal. 
2013 Apr;38(2):97-9. 
90 
 
99. Subramanyam NT, Kumar N, Vakrani GP. Carotid artery stenosis, Stroke, 
Ultrasonography. EVALUATION OF CAROTID ARTERY STENOSIS IN 
STROKE/TRANSIENT ISCHAEMIC ATTACK.. 2015 Oct 7(8366). 
100. Schroll M. The World Health Organization MONICA Project: a major 
international collaboration. J Clin Epidemiol. 1988;41:105–114 
101. Badiger S, Akkasaligar PT, Sandeep HM, Biradar MS. Microalbuminuria in 
Essential Hypertension. World Academy of Science, Engineering and Technology, 
International Journal of Medical, Health, Biomedical, Bioengineering and 
Pharmaceutical Engineering. 2011 Dec 20;5(12):716-20. 
102. Diercks GF, Hillege HL, van Boven AJ, Kors JA, Crijns HJ, Grobbee DE, de Jong 
PE, van Gilst WH: Microalbuminuria modifies the mortality risk associated with 
electrocardiographic ST-T segment changes. J Am Coll Cardiol40 :1401 ,2002 
103. Molitch ME, Steffes M, Sun W, Rutledge B, Cleary P, De Boer IH, Zinman B, 
Lachin J. Development and progression of renal insufficiency with and without 
albuminuria in adults with type 1 diabetes in the diabetes control and 
complications trial and the epidemiology of diabetes interventions and 
complications study. Diabetes care. 2010 Jul 1;33(7):1536-43. 
104. Koulouris S, Lekatsas I, Karabinos I, Ioannidis G, Katostaras T, Kranidis A, 
Triantafillou K, Thalassinos N, Anthopoulos L. Microalbuminuria: a strong 
91 
 
predictor of 3-year adverse prognosis in nondiabetic patients with acute 
myocardial infarction. American heart journal. 2005 May 31;149(5):840-5. 
105. Apostolovic S, Stanojevic D, Djordjevic V, Tomasevic RJ, Martinovic SS, 
Radojkovic DD, Koracevic G, Stojanovic I, Pavlovic M. Prognostic significance 
of microalbuminuria in patients with acute myocardial infarction. Clinical 
laboratory. 2010 Dec;57(3-4):229-35 
106. Atthobari, J., Asselbergs, F.W., Boersma, C., de Vries, R., Hillege, H.L., van 
Gilst, W.H., Gansevoort, R.T., de Jong, P.E., Postma, M.J. and PREVEND IT 
Study Group, 2006. Cost-effectiveness of screening for albuminuria with 
subsequent fosinopril treatment to prevent cardiovascular events: A 
pharmacoeconomic analysis linked to the prevention of renal and vascular 
endstage disease (PREVEND) study and the prevention of renal and vascular 
endstage disease intervention trial (PREVEND IT). Clinical therapeutics, 28(3), 
pp.432-444. 
 
 
 
 
 
 
 
 
 ETH
A
ICAL CLE
PPENDIC
ARANCE
 
ES 
 CERTIFICATE 
92 
 
93 
 
18. INVESTIGATOR DECLARATION 
• I certify that the research proposal here is not necessarily the duplicate of 
previously reported research 
• I will obtain approval from Institution Research Committee (IRC) & Institution 
Human Ethics Committee (IHEC) of SMIMS, before starting my research proposal. 
• I will obtain the approval from IRC and IHEC before initiating any significant 
changes in the study 
• I certify that performances of research will be carried out in accordance with the 
GCP & GLP guidelines laid by international & national organizations from time to 
time. 
• I will maintain all records pertaining to my research activities and will produce 
before the IHEC for scrutiny if required. 
Date:                                                  
Place: 
                                                                               Signature of Principal Investigator                      
Dr Jayaram J.K. 
Post Graduate, Department of General Medicine 
Sree Mookambika Institute of Medical Sciences 
Kulasekharam, 629161 
Mobile Number: 09566563322 
e-mail:jayaramj24@gmail.com 
 
94 
 
 
Signature of Guide: Dr Thilagar     Signature of HOD 
Professor , Department of General Medicine                 Dr.Kaniraj Peter MD             
Sree Mookambika Institute of                              
Medical Sciences                                                                                  
Kulasekharam, 629161                                                                                
Contact No:9367524551 
Email id:dr.thilagar55@gmail.com 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
95 
 
CONSENT FORM 
PART 1 OF 2 
INFORMATION FOR PARTICIPANTS OF THE STUDY 
Dear Volunteers, 
      We welcome you and thank you for your keen interest in participating in this 
research project. Before you participate in this study, it is important for you to 
understand why this research is being carried out. This form will provide you all 
the relevant details of this research. It will explain the nature, the purpose, the 
benefits, the risks, the discomfort, the precautions and the information about how 
this project will be carried out. It is important that you can read and understand the 
contents of the form carefully. This form may contain certain scientific terms and 
hence, if you have any doubts or if you want more information, you are to ask the 
study personnel or the contact person mentioned below before you give your 
consent and also at any time during the entire course of the project. 
 
1. Name of the Principal Investigator:    Dr.Jayaram J k 
Postgraduate – M.D General Medicine 
SreeMookambika Institute of Medical Sciences 
Kulasekharam 
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2. Name of the Guide: Dr.Thilagar 
                                            Professor  
    Department of General Medicine 
                                                        SreeMookambika Institute of Medical   Sciences 
             Kulasekharam 
 
3. Institute: details with Address:   SreeMookambika Institute of Medical       
Sciences  Kulasekharam 
     Kanyakumari District-629161 
     Tamil Nadu 
 
4. Title of the study:  STUDY ON MICROALBUMINURIA IN ISCHEMIC 
STROKE  PATIENTS AT SMIMS KULASEKHARAM  
5. Background Information: 
Microalbuminuria, a marker of endothelial dysfunction is associated with 
global vascular risk but the nature and magnitude of link between microalbuminura 
and incident stroke has not been clearly defined. 
Purpose of the study is to assess the strength of association between 
microalbuminuria and incidence of ischemic stroke. 
 
 
 
97 
 
6. Aims and Objectives: 
To study incidence of microalbuminuria in patients with acute ischemic 
stroke that is less than 24 hours. (small vessel or large vessel  disease) 
Relationship of microalbuminuria to risk factor for stroke. 
Prevalence of microalbuminuria in major subtypes of ischemic strokes.( Small 
vessel or large vessel disease ). 
7. Scientific justification of the study: 
Assessing Microalbinuria using simple test could be a window to systemic 
vasculature in general and individuals susceptible to target organ damage. There is 
convincing evidence of an independent positive relationship between overt 
proteinuria and stroke risk,but the nature and magnitude of the link between 
microalbuminuria and incident stroke has so far not been systematically 
investigated. In this study,we aim to assess the consistency and strength of the 
association of microalbuminuria with incidence of ischemic stroke and  association 
with risk factors. 
8. Procedure of the study:Patients with acute ischemic stroke confirmed by CT of 
the brain admitted to medical ward of SMIMS Kulasekharam will be are includedA 
detailedmedical history willbe taken and a detailed general physical examination 
will be performed.Vitals recording and detailed CNS examination and examination 
of other systems will be done.Urine samples to assess urinary albumin level will be 
sent to central lab – where urine spot examination in semi-automatic analyser will 
be done to assess urine albumin level. 
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9. Expected risk of the participants:No risk 
10. Expected Benefits of the Research for the participants:Screening for 
microalbuminuria. 
11. Maintenance of confidentiality: 
All data collected for the study will be kept confidential and will only reflect 
on the general statistical evaluation but will not reveal any personal details. 
12. Why have I been chosen to be in this study: 
You have ischemic stroke and fulfill the criteria of selection 
13. How many people will be in the study:50 
14. Agreement of compensation to the participants:No 
15. Anticipated prorated payment, if any,to the participants of the study:Nil 
16. Can I withdraw from study at any time during the study period:Yes 
17. If there is any new finding/information, would I be informed:Yes 
18. Expected duration of the participants participation in the study:Single visit 
19. Any other pertinent information:No 
20. Whom do I contact for further information:Dr. Jayaram JK 
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For any study related queries,you are free to contact: 
 
Dr. JAYARAM J K 
Post Graduate – DEPARTMENT OF GENERAL MEDICINE 
SreeMookambika Institute of Medical Sciences, 
Kulasekharam 
Mobile number: 09566563322 
e-mail: jayaramj24@gmail.com 
 
 
 
Place:                            
Date: 
                                                                         Signature of Principal Investigator  
 
 Signature of Participant 
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CONSENT FORM 
PART 2 OF 2 
PARTICIPANTS CONSENT FORM 
The details of the study have been explained to me in writing and details 
have been fully explained to me. I am aware that the results of the study may not be 
directly beneficial to me but will help in the advancement of medical sciences. I 
confirm that I have understood the study and had the opportunity to ask questions. I 
understand that my participation in the study is voluntary and that I am free to 
withdraw at any time, without giving any reasons, without the medical care that 
normally is provided by the hospital being affected. I agree not to restrict the use of 
any data or results that arise from this study provided such a use is only for 
scientific purpose(s). I have given details of the study. I fully consent to participate 
in the study titled  Microalbuminuria in acute Ischemic stroke in a tertiary medical 
care centre, Kulasekharam. 
Serial no/Reference no: 
Name and Address of the participant:                                                       
 
Contact number of the Participant: 
                                               Signature/Thumb impression of the participant/Legal guardian 
Witness 
       1. 
       2. 
Date: 
Place: 
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1. Age distribution 
2. Gender distribution  
3. Pulse 
4. Systolic BP  
5. Diastolic BP 
6. GCS 
7. Cranial nerve involvement 
8. Facial nerve involvement 
 
9. Motor system power of affected limb 
10. Urine microalbumin 
11. ECG showing LVH  
12. Correlation of microalbuminuria with blood pressure 
13. Correlation of microalbuminuria with RBS 
14. Correlation of microalbuminuria with vascular territory 
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Figures 
1. Circle of Willis 
2. Types of Stroke 
3. Modifiable risk factors for stroke 
4. Non-modifiable risk factors for stroke 
5. Function loss and domain relationship 
6. Vascular territories  
7. Confounders of microalbuminuria. 
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 KEY TO MASTER CHART 
S. No: Serial number 
IP no: Inpatient number 
Sex:   M- Male 
          F – Female 
Presenting Complaints:  W - Weakness 
Pulse:  Bpm – Beats per minute 
BP: Blood Pressure 
GCS – Glassgow coma scale 
      E – Eye opening 
      V – Verbal response 
      M – Motor response 
HMF – Higher Mental Function 
• C - Conscious 
CN involvement – Cranial nerve involvement 
• I – involved 
• NI – not involved 
Facial – Facial nerve involvement 
 
 
 
 
 Motor System – Power 
• 0 – No response 
• 1 – Flickering movement 
• 2 – Movement with gravity eliminated 
• 3 – Movement against gravity 
• 4 – Movement against resistance 
• 5- Normal movement 
Sensory System:      NA – Not affected 
Meningeal involvement:    A – Absent 
Skull & spinal cord: N – Normal                                     
CVS – Cardiovascular System 
      S1 – First heart sound 
      S2 – Second heart sound 
RS – Respiratory system 
       B/L NVBS – Bilateral Normal Vesicular Breath Sound 
Abdomen: N - Normal 
RBS – Random Blood Sugar 
Urine microalbumin:   1. P – Present                  
                                     2. A - Absent 
TC – Total cholesterol 
TG – Triglycerides 
 LDL – Low density Lipoprotein 
HDL – High density Lipoprotein 
ECG – Electrocardiography 
• LVH – Left ventricular hypertrophy 
• P – Present 
• A - Absent 
CT Brain infarct:  P - Present 
Territory:  M – Middle cerebral artery 
                   P – Posterior cerebral artery 
                   A – Anterior cerebral artery 
 
 
 
 
